B4galt4tm1(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
B4galt4tm1(KOMP)Wtsi |
Name: |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4; targeted mutation 1, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4419597 |
Gene: |
B4galt4 Location: Chr16:38562626-38589411 bp, + strand Genetic Position: Chr16, 26.87 cM, cytoband B4
|
IMPC: |
B4galt4 gene page |
|
Mutant Cell Lines: |
EPD0375_6_A04, EPD0375_6_D02, EPD0375_6_E03, EPD0375_6_F03 |
Germline Transmission: |
Unknown
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The insertion of the L1L2_Bact_P cassette created a deletion of size 9329 starting at position 38574279 and ending at position 38583608 of Chromosome 16 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site.
(J:148605, J:173534)
|
|
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
2 reference(s) |
|